Table 4.
MSD | 8/8MUD | 7/8MUD | UCB | |
---|---|---|---|---|
Relapse/progression | 42 (38.2) | 99 (37.6) | 57 (36.1) | 117 (33.3) |
Infection | 22 (20.0) | 52 (19.8) | 33 (20.9) | 86 (24.5) |
GVHD | 10 (9.1) | 25 (9.5) | 14 (8.9) | 21 (6.0) |
Pulmonary complication | 12 (10.9) | 29 (11.0) | 18 (11.4) | 39 (11.1) |
Organ failure | 12 (10.9) | 23 (8.7) | 10 (6.3) | 26 (7.4) |
Hemorrhage | 5 (4.5) | 11 (4.2) | 8 (5.1) | 19 (5.4) |
SOS/TMA | 2 (1.8) | 11 (4.2) | 4 (2.5) | 16 (4.6) |
Secondary cancer | 2 (1.8) | 8 (3.0) | 6 (3.8) | 9 (2.6) |
Graft failure | 2 (1.8) | 2 (0.8) | 5 (3.2) | 10 (2.8) |
Exogeneous deaths | 1 (0.9) | 1 (0.4) | 0 | 1 (0.3) |
Unknown | 0 | 2 (0.8) | 3 (1.9) | 7 (2.0) |
GVHD graft-versus-host disease, SOS sinusoidal obstruction syndrome, TMA thrombotic microangiopathy.